Equity - Incentive Equity Awards - Summary of Euity Awards Activity (Details) - USD ($)		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
Stockholders Equity Note [Line Items]
Stock Options Issued		25,247	810,459
Gross Proceeds		$ 49,000	$ 2,134,000
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Common Shares Issued in settlement of RSUs and Performance Based RSUs Vested		681,216	1,031,171
Shares retained for settlement of employee tax obligations		222,634	398,214
Performance-Based RSUs
Stockholders Equity Note [Line Items]
Common Shares Issued in settlement of RSUs and Performance Based RSUs Vested	[1]		1,762,244
Shares retained for settlement of employee tax obligations			747,955

[1] Performance-based RSUs vested in connection with the achievement of certain regulatory and sales performance conditions associated with the REDUCE-IT clinical trial and subsequent revenue growth. These performance-based RSUs have fully vested as of August 2021.